BioTricity Inc. Files 8-K for Material Agreement
Ticker: BTCY · Form: 8-K · Filed: Jun 24, 2024 · CIK: 1630113
| Field | Detail |
|---|---|
| Company | Biotricity INC. (BTCY) |
| Form Type | 8-K |
| Filed Date | Jun 24, 2024 |
| Risk Level | medium |
| Pages | 7 |
| Reading Time | 9 min |
| Key Dollar Amounts | $0.001 B, $0.001, $9,090.91, $500,000, $1,500,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, corporate-filing
TL;DR
BioTricity Inc. signed a big deal and sold some stock, filing an 8-K on June 21, 2024.
AI Summary
On June 21, 2024, BioTricity Inc. entered into a material definitive agreement, the details of which are not fully disclosed in this filing. The company also reported on unregistered sales of equity securities and filed financial statements and exhibits. This filing follows a period of activity for the company, which was formerly known as MetaSolutions, Inc. and incorporated in Nevada.
Why It Matters
This 8-K filing indicates significant corporate activity for BioTricity Inc., including a new material agreement and equity transactions, which could impact its financial standing and future operations.
Risk Assessment
Risk Level: medium — The filing mentions unregistered sales of equity securities and a material definitive agreement, which can introduce financial and operational risks if not managed properly.
Key Numbers
- 001-40761 — SEC File Number (Identifies the company's filing history with the SEC.)
Key Players & Entities
- BIOTRICITY INC. (company) — Registrant
- MetaSolutions, Inc. (company) — Former company name
- June 21, 2024 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
FAQ
What is the nature of the material definitive agreement entered into by BioTricity Inc. on June 21, 2024?
The specific details of the material definitive agreement are not disclosed in this 8-K filing, which only reports its entry.
What type of equity securities were sold by BioTricity Inc. under the unregistered sales provision?
This 8-K filing states that there were unregistered sales of equity securities, but does not specify the type or amount of securities sold.
When was BioTricity Inc. incorporated, and in which state?
BioTricity Inc. was incorporated in Nevada.
What was BioTricity Inc.'s former company name?
BioTricity Inc.'s former company name was MetaSolutions, Inc.
What is the principal executive office address for BioTricity Inc.?
The principal executive office address for BioTricity Inc. is 203 Redwood Shores Parkway, Suite 600, Redwood City, California 94065.
Filing Stats: 2,144 words · 9 min read · ~7 pages · Grade level 15 · Accepted 2024-06-24 09:25:04
Key Financial Figures
- $0.001 B — ch registered Common Stock, Par Value $0.001 BTCY Nasdaq Capital Market Indicate
- $0.001 — s Series B Convertible Preferred Stock, $0.001 par value (the "Series B Preferred Stoc
- $9,090.91 — eferred Stock"), at a purchase price of $9,090.91 per share of Series B Convertible Prefe
- $500,000 — Preferred Stock, for gross proceeds of $500,000 (the "First Closing"). The First Closin
- $1,500,000 — 1 per share for gross proceeds of up to $1,500,000. Pursuant to the Purchase Agreement, th
- $10,000 — B Preferred Stock has a stated value of $10,000 per share (the "Stated Value"). The S
- $3 — price. The initial conversion price is $3.50, subject to adjustment in the event
Filing Documents
- form8-k.htm (8-K) — 61KB
- ex10-1.htm (EX-10.1) — 371KB
- ex10-2.htm (EX-10.2) — 11KB
- ex10-3.htm (EX-10.3) — 44KB
- 0001493152-24-024888.txt ( ) — 753KB
- btcy-20240621.xsd (EX-101.SCH) — 3KB
- btcy-20240621_lab.xml (EX-101.LAB) — 33KB
- btcy-20240621_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: June 21, 2024 BIOTRICITY INC. By: /s/ Waqaas Al-Siddiq Waqaas Al-Siddiq Chief Executive Officer